Tanzania

Nearly 56 million people in Tanzania are at risk for one or more neglected tropical disease (NTD). The country is endemic for all five NTDs targeted by USAID’s Act | East program: lymphatic filariasis (LF), onchocerciasis, trachoma, schistosomiasis, and soil-transmitted helminth infections.

Since 2010, USAID has supported Tanzania’s Ministry of Health to reach its NTD control and elimination goals, with a focus on mass treatment for all five diseases, disease specific assessments, and mapping. As a result, Tanzania has made remarkable progress: 81% of people living in LF-endemic areas are no longer at risk for the disease, and 92% of people living in endemic areas are no longer at risk for trachoma (as of 2021).

Our Focus

Act | East is implemented in Tanzania by RTI International. The program continues USAID’s focus on the elimination of LF, trachoma and onchocerciasis from the country, through support for mass drug administration campaigns, impact surveys, and dossier development. Act | East also supports national school-based deworming efforts, health system strengthening initiatives, and support for gender and social inclusion activities as they relate to NTDs.